Observational data reveals breast density alterations in women with BRCA1 or BRCA2 mutations undergoing surgery, suggesting implications for monitoring risk.
Supplemental Table 5 includes changes in total breast area among women with a pathogenic germline variant in BRCA1 or BRCA2 who did or did not undergo risk-reducing salpingo-oophorectomy in the interval between mammograms
No takes yet. Share an insight, caveat, or question.
Loehrer et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: